Equities

Theraclion SA

Theraclion SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.364
  • Today's Change0.00 / 0.00%
  • Shares traded2.14k
  • 1 Year change-46.31%
  • Beta0.2388
Data delayed at least 15 minutes, as of Apr 15 2024 14:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Theraclion SA is a France-based company, which develops High Intensity Focused Ultrasound (HiFu) machines. The Company is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The Company provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

  • Revenue in EUR (TTM)1.87m
  • Net income in EUR-4.88m
  • Incorporated2004
  • Employees30.00
  • Location
    Theraclion SA244, avenue Pierre BrossoletteMALAKOFF 92240FranceFRA
  • Phone+33 155489070
  • Fax+33 155489078
  • Websitehttps://www.theraclion.fr/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Implanet SA7.45m-6.68m9.25m41.00------1.24-0.1704-0.17040.1933-0.00420.59310.90834.19182,973.00-53.17-37.44-159.90-86.7456.8359.59-89.65-67.430.2932-24.761.03---7.242.08-88.59---2.20--
Spineguard SA5.29m-3.23m11.68m24.00--1.57--2.21-0.0899-0.08990.14890.15690.44151.476.19229,895.20-26.94-21.36-37.72-41.3874.3877.29-61.01-33.681.76-7.560.3553--27.11-7.29-38.75--55.68--
Laboratoires Euromedis SA49.54m-5.51m12.56m194.00--0.4504--0.2536-1.84-1.8416.469.700.82833.544.88255,371.10-9.19---11.45--32.67---11.09--3.57-12.830.2875---51.58---362.99------
Alpha Mos SA6.16m-3.39m15.55m48.00------2.52-0.3105-0.31050.5637-0.50660.84242.244.99128,270.80-46.70-50.01-481.38-102.4971.2768.37-55.43-74.150.4423-10.7611.30--2.257.46-39.13--7.59--
Theraclion SA1.87m-4.88m16.65m30.00--2.46--8.90-0.1362-0.13620.05040.14810.10210.2821.2366,785.00-26.65-40.08-35.36-59.9654.2152.19-260.94-276.132.50-56.170.2546---16.58-12.66-32.02--11.77--
Diagnostic Medical Systems SA37.53m3.02m19.92m120.007.161.103.670.53090.15770.02832.171.030.71461.694.58320,760.703.97-11.146.98-19.5239.4937.795.55-15.540.8608-5.700.5059---4.575.40-44.25------
Mauna Kea Technologies SA10.90m-2.17m24.45m67.00----22.732.24-0.0488-0.04880.2449-0.33860.52652.016.73194,696.40-2.61-58.19-5.19-83.9137.11-1.33-4.96-182.400.740529.852.22---2.872.2616.85---27.66--
Novacyt SA9.21m-29.59m41.87m222.00--0.3334--4.55-0.419-0.42040.13041.780.05281.330.262241,478.52-16.9617.69-20.7123.8243.2162.82-321.4023.874.98-79.020.00360.00-77.2813.49-269.46---13.46--
Visiomed Group SA12.04m-3.54m63.29m73.00--2.77--5.25-0.0119-0.01190.04060.07760.34531.406.88174,550.70-10.44-53.01-12.11-127.0991.4641.03-30.24-99.081.70-9.310.2631--101.386.67-18.40--52.36--
Affluent Medical SAS0.00-15.02m65.96m52.00--1.58-----0.6596-0.65960.001.260.00----0.00-23.91-23.11-27.18-26.49-----------10.510.2905-------2.75---11.10--
Data as of Apr 15 2024. Currency figures normalised to Theraclion SA's reporting currency: Euro EUR

Institutional shareholders

4.67%Per cent of shares held by top holders
HolderShares% Held
DNCA Finance SAas of 30 Jun 20211.09m2.39%
Friedland Gestion SASas of 29 Dec 2023779.19k1.70%
OFI Invest Asset Management SAas of 29 Feb 2024261.90k0.57%
Data from 29 Dec 2023 - 10 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.